Primary mediastinal extraskeletal osteosarcoma on 18F-fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (PET/CT): a case description

被引：0
|
作者：
Yang, Zhimin [1 ]
Wang, Jianfeng [1 ,2 ]
Feng, Jinbao [1 ]
Shi, Yunmei [1 ]
Wang, Yuetao [1 ]
Niu, Rong [1 ,2 ]
机构：
[1] Soochow Univ, Affiliated Hosp 3, Dept Nucl Med, 185 Juqian St, Changzhou 213003, Peoples R China
[2] Soochow Univ, Inst Clin Translat Nucl Med & Mol Imaging, Changzhou 213003, Peoples R China
来源：
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY | 2024年 / 14卷 / 09期
关键词：
D O I：
10.21037/qims-24-467
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：7004 / 7011
页数：8
相关论文
共 50 条
  • [41] Preoperative staging of clinically node-negative esophageal cancer by the combination of 18F-fluorodeoxyglucose positron emission tomography and computed tomography (FDG–PET/CT)
    Masahiko Yano
    Masaaki Motoori
    Koji Tanaka
    Kentaro Kishi
    Yoshiyuki Fujiwara
    Tatsushi Shingai
    Kunihito Gotoh
    Hidenori Takahashi
    Shingo Noura
    Terumasa Yamada
    Masayuki Ohue
    Hiroaki Ohigashi
    Osamu Ishikawa
    Esophagus, 2012, 9 : 210 - 216
  • [42] 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (FDG PET) RESPONSE PREDICTS SURVIVAL IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA
    Abdelsalam, M.
    El Weshi, A.
    Abouzied, M.
    Al Husseini, H.
    Soudy, H.
    Darwish, A.
    Mohamed, A.
    Al-Sugair, A.
    Khafaga, Y.
    Akhtar, I. Maghfoor Saad
    Akhtar, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 115 - 115
  • [43] Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer
    Ueda, Shigeto
    Tsuda, Hitoshi
    Asakawa, Hideki
    Shigekawa, Takashi
    Fukatsu, Kazuhiko
    Kondo, Nobuo
    Yamamoto, Mikio
    Hama, Yukihiro
    Tamura, Katsumi
    Ishida, Jiro
    Abe, Yoshiyuki
    Mochizuki, Hidetaka
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (04) : 250 - 258
  • [44] The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis
    Paez, Diana
    Giammarile, Francesco
    Brink, Anita
    Garcia-Perez, Osvaldo
    Estrada-Lobato, Enrique
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (03) : 409 - 414
  • [45] Validation of FDG Uptake in the Arterial Wall as an Imaging Biomarker of Atherosclerotic Plaques with 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG-PET/CT)
    Bucci, Monica
    Aparici, Carina Mari
    Hawkins, Randy
    Bacharach, Steve
    Schrek, Carole
    Cheng, SuChun
    Tong, Elizabeth
    Arora, Sandeep
    Parati, Eugenio
    Wintermark, Max
    JOURNAL OF NEUROIMAGING, 2014, 24 (02) : 117 - 123
  • [46] 18F-fluorodeoxyglucose positron emission tomography/computed tomography for primary thyroid langerhans histiocytosis: A case report and literature review
    Long, Qi
    Wang Shaoyan
    Hui, Wang
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2015, 30 (04): : 328 - 330
  • [47] Inflammatory pseudotumour of the spleen: the findings on F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT)
    Ryu, Je Seock
    Um, Jun Won
    Min, Byung Wook
    ANZ JOURNAL OF SURGERY, 2010, 80 (09) : 650 - 652
  • [48] The diagnostic value of [18F]-fluorodeoxyglucose (FDG)-positron emission tomography-computed tomography (PET/CT) for urachal cancer
    Stokkel, L. E.
    Stokkel, M. P.
    Donswijk, M. L.
    Lahaye, M. J.
    Van Rhijn, B. W. G.
    Mertens, L.
    EUROPEAN UROLOGY, 2021, 79 : S963 - S964
  • [49] Fluorodeoxyglucose positron-emission tomography (FDG PET)/computed tomography (CT) in bladder cancer
    Goh, Vicky
    Cook, Gary
    BJU INTERNATIONAL, 2013, 112 (06) : 709 - 709
  • [50] The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies
    Tian, JH
    Chen, L
    Wei, B
    Shao, MZ
    Ding, Y
    Yin, DY
    Yao, SL
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (08) : 825 - 831
12345